Afp and Hcg in Germ Cell Tumors

@article{Bassetto1994AfpAH,
  title={Afp and Hcg in Germ Cell Tumors},
  author={M. A. Bassetto and T. Franceschi and M. Lenotti and G. Parise and F. Pancheri and R. Sabbioni and M. Zaninelli and G. Cetto},
  journal={The International Journal of Biological Markers},
  year={1994},
  volume={9},
  pages={29 - 32}
}
  • M. A. Bassetto, T. Franceschi, +5 authors G. Cetto
  • Published 1994
  • Medicine
  • The International Journal of Biological Markers
    • The high specificity and sensitivity of testicular tumor markers make them particularly useful in the management of these neoplasms. Basal value represents an independent prognostic variable, influencing the choice of therapy. An increase in marker level before chemotherapy could also acquire a powerful prognostic significance. The decay curve pattern is indicative of the radicality of surgery. Also during chemotherapy the behavior of markers conditions further therapeutic strategies. 
    View on SAGE
    ncbi.nlm.nih.gov
    10 Citations
    Background Citations
    2

    Figures and Topics from this paper

    Figures

    Explore Further: Topics Discussed in This Paper

    10 Citations
    Citation Type

    Citation Type

    The serum level of markers during chemotherapy as prognostic indicator in testicular GCT
    Serum Tumor Marker Test Profile in Testicular Germ-Cell Tumors
    Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
    • 12
    Fetus-in-fetu with malignant recurrence.
    • 105
    Fetus in fetu--diagnostic criteria and differential diagnosis--a case report and literature review.
    • 73
    Fetus in Fetu: A Case Report & Review of Literatures
    • 1
    • PDF
    Giant retroperitoneal fetus-in-fetu: An unusual cause of respiratory distress
    • 5
    Fetus-in-fetu in Botswana
    Behandlungsergebnisse von Patienten mit nicht-seminomatösen Hodentumoren aus dem Universitätsklinikum des Saarlandes zwischen 1975 und 2005
    Untersuchungen der Tumor M2-Pyruvatkinase zur Kinetik und Bedeutung als Tumormarker bei malignen Keimzelltumoren des Hodens

    References

    SHOWING 1-10 OF 17 REFERENCES
    Prognostic factors in metastatic testicular cancer.
    • 40
    Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy.
    • 172
    Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery
    • 30
    Biological markers in urologic cancer
    • 27
    Serum tumour marker regression rate following chemotherapy for malignant teratoma.
    • 30
    The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
    • 21
    Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
    • 115
    • PDF
    Prognostic significance of a decline in serum human chorionic gonadotropin levels after initial chemotherapy for advanced germ-cell carcinoma.
    • 58
    The growth rate of metastatic non-seminomatous germ cell testicular tumours measured by marker production doubling time--I. Theoretical basis and practical application.
    • 15
    Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.
    • 22